Fractyl Health, Inc. - Enterprise Value

The Enterprise Value as of July 2026 (TTM) for Fractyl Health, Inc. (GUTS) is 47.46M

According to Fractyl Health, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 47.46M. This represents a change of -50.75% compared to the average of 96.37M of the last 4 quarters.

Fractyl Health, Inc. (GUTS) Historical Enterprise Value (quarterly & annually)

How has GUTS Enterprise Value performed in the past?

The mean historical Enterprise Value of Fractyl Health, Inc. over the last ten years is 584.61M. The current 47.46M Enterprise Value has changed 711.86% with respect to the historical average. Over the past ten years (40 quarters), GUTS's Enterprise Value was at its highest in in the December 2023 quarter at 951.95M. The Enterprise Value was at its lowest in in the March 2020 quarter at 0.

Fractyl Health, Inc. (GUTS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Fractyl Health, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Fractyl Health, Inc. (GUTS) Average Enterprise Value

How has GUTS Enterprise Value performed in the past?

The current Enterprise Value of Fractyl Health, Inc. (GUTS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Fractyl Health, Inc. (GUTS) Enterprise Value vs. Peers

How is GUTS’s Enterprise Value compared to its peers?

Fractyl Health, Inc.’s Enterprise Value is less than Adverum Biotechnologies, Inc. (159.14M), less than ALX Oncology Holdings Inc. (234.66M), greater than Precision BioSciences, Inc. (17.48M), less than Artiva Biotherapeutics, Inc. (236.97M), less than Sutro Biopharma, Inc. (165.62M), greater than Quince Therapeutics, Inc. (-11632024.00), less than Metagenomi, Inc. Common Stock (59.43M), greater than Repare Therapeutics Inc. (41.75M), less than aTyr Pharma, Inc. (49.05M), greater than Biomea Fusion, Inc. (44.75M),

Build a custom stock screener for Fractyl Health, Inc. (GUTS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Fractyl Health, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Fractyl Health, Inc. (GUTS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Fractyl Health, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.